ScoreWhy is Pfizer Inc. ?
1
High Management Efficiency with a high ROCE of 16.86%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 2.16 times
3
The company has declared Positive results for the last 3 consecutive quarters
- NET PROFIT(9M) At USD 11,738.38 MM has Grown at 53.8%
- DIVIDEND PER SHARE(HY) Highest at USD 5.44
- RAW MATERIAL COST(Y) Fallen by -3.65% (YoY)
4
With ROCE of 12.73%, it has a very attractive valuation with a 1.99 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 2.26%, its profits have risen by 120.4% ; the PEG ratio of the company is 0.1
- At the current price, the company has a high dividend yield of 428.1
5
Underperformed the market in the last 1 year
- The stock has generated a return of 2.26% in the last 1 year, much lower than market (S&P 500) returns of 14.11%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Pfizer Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Pfizer Inc. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Pfizer Inc.
7.22%
-0.30
26.68%
S&P 500
22.99%
0.70
20.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.60%
EBIT Growth (5y)
7.85%
EBIT to Interest (avg)
12.68
Debt to EBITDA (avg)
2.16
Net Debt to Equity (avg)
0.50
Sales to Capital Employed (avg)
0.39
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
126.85%
Pledged Shares
0
Institutional Holding
70.00%
ROCE (avg)
16.86%
ROE (avg)
21.23%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
3.00
EV to EBIT
17.76
EV to EBITDA
12.91
EV to Capital Employed
2.25
EV to Sales
4.97
PEG Ratio
0.74
Dividend Yield
281.45%
ROCE (Latest)
12.69%
ROE (Latest)
19.63%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
DIVIDEND PAYOUT RATIO(Y)
Highest at 91.72%
-3What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 7.05% (YoY
NET PROFIT(Q)
Lowest at USD 3,045.25 MM
Here's what is working for Pfizer Inc.
Dividend Payout Ratio
Highest at 91.72% and Grown
In each year in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Here's what is not working for Pfizer Inc.
Net Profit
Lowest at USD 3,045.25 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Net Profit
At USD 3,045.25 MM has Fallen at -28.07%
over average net sales of the previous four periods of USD 4,233.85 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Raw Material Cost
Grown by 7.05% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
